ClinicalTrials.Veeva

Menu

Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients

A

Assiut University

Status

Not yet enrolling

Conditions

Pain Management
Facial Palsy
Stellate Ganglion

Treatments

Drug: Stellate Ganglion Block

Study type

Observational

Funder types

Other

Identifiers

NCT06742255
Stellate ganglion facial palsy

Details and patient eligibility

About

The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain

Enrollment

34 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • facial nerve palsy patients

Exclusion criteria

  1. light of a recent myocardial infarction.
  2. anticoagulant use
  3. glucoma
  4. lateral nerve palsy
  5. emphysema
  6. cardiac conduction abnormalities
  7. active infection, flu, cold
  8. uncontrolled cough
  9. Fever
  10. Very high blood pressure or if you are on blood thinners.
  11. allergic reaction to local anesthetics
  12. Primary and secondary coagulopathy.

Trial design

34 participants in 2 patient groups

stellate ganglion block group
Treatment:
Drug: Stellate Ganglion Block
medical treatment group

Trial contacts and locations

0

Loading...

Central trial contact

Remonda Zaki Abd El Naeem

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems